CD33 and acute myeloid leukemia: Jedema and colleagues have previously noted that the failure of excess free CD33 antibody to block GO-mediated toxicity in primary AML blasts is concentration-dependent, and occurs at concentrations greater than 1 ng/ml (we used 10 ng/ml in the current study)[50].